Overton’s confirmation over
Presented by Coalition to Strengthen Americas Healthcare {beacon} Healthcare Healthcare The Big Story Overton’s confirmation over Permanent leadership of the Food and Drug Administration is in limbo after the White House late Tuesday suddenly withdrew the nomination of Heidi Overton to be the agency’s commissioner. © Greg Nash Overton was set to face a key vote…
Permanent leadership of the Food and Drug Administration is in limbo after the White House late Tuesday suddenly withdrew the nomination of Heidi Overton to be the agency’s commissioner.
Overton was set to face a key vote today in the Senate health committee. While members had outstanding questions and concerns , panel chairman Sen. Bill Cassidy (R-La.) seemed to think those had been addressed and Overton was going to clear the committee and head to the floor.
Cassidy said he was taken by surprise because he thought Overton had the votes to advance. Sen. Patty Murray (D-Wash.) said on Tuesday that she was committed to ensuring Overton’s confirmation did not advance, citing her past criticisms of the abortion pill mifepristone.
“We have decades of proof that medication abortion is safe and effective. Millions upon millions of women have used this medication,” Murray said in a statement. “But in our hearing, Dr. Overton would not say what the science has said for years now: that the abortion pill is safe and effective. At the same time, she also tried to avoid acknowledging her past claims that the abortion pill was ‘dangerous’—perhaps because she knows they are embarrassingly wrong.”
FDA thrives on stability and predictability, and the lack of a confirmed leader makes that difficult.
Under former commissioner Marty Makary, the agency had lost trust and was viewed as politically charged . There has been a period of relative calm under acting commissioner Kyle Diamantas, but he has reportedly declined to take the role permanently.
The next head of the agency will have to navigate many of the same headwinds — political interference, funding cuts and balancing the demands of the “Make America Healthy Again” (MAHA) movement with the MAGA White House — that Makary faced.
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pushing untested peptides with virtually no restrictions. Anti-abortion leaders and lawmakers want the agency to restrict access to the abortion pill mifepristone.
With just two months left until Democrats are set to take control of Congress, the Trump administration will likely have to contend with sending a new FDA nominee before a Senate controlled 56-44 by Democrats.
Welcome to The Hill’s Healthcare newsletter , we’re Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health.
Did someone forward you this newsletter? Subscribe here.
How policy will be impacting the healthcare sector this week and beyond:
Pennsylvania health officials and the Centers for Disease Control and Prevention (CDC) on Wednesday reported the commonwealth’s eighth measles-related death this year, one day after the U.S. lost its measles elimination status after 25 years. The state’s Department of Health said an unvaccinated Clinton County resident initially tested positive for the virus before their death. Pennsylvania has seen 1,589 confirmed …
The National Institutes of Health (NIH) announced Wednesday it will release the last government-owned research chimpanzees in early 2027 to a sanctuary, ending a decade-long effort to get the animals out of federal laboratories. The 34 chimpanzees, currently housed at the Keeling Center for Comparative Medicine and Research in Bastrop, Texas, will be transferred to Chimp Haven, a 200-acre Louisiana sanctuary that serves as …
Two lawmakers shared how they have personally been impacted by Alzheimer’s and pushed for bipartisan legislation that would provide Medicare coverage for early blood testing for this disease and other dementias during a Wednesday event hosted by The Hill. Sen. Kevin Cramer (R-N.D.) and Rep. Nanette Barragán (D-Calif.) are both advocating for the passage of the Alzheimer’s Screening and Prevention (ASAP) Act. Cramer …
Branch out with a different read from The Hill:
Trump officials seek to ease anxiety over sweeping tech outages
The Trump administration is seeking to calm Americans about a series of tech outages that have raised public anxiety and spurred questions about whether there is a larger problem.
Local and state headlines on healthcare:
Massachusetts approves drive-thru sales at marijuana dispensaries ( Boston 25 )
Texas sees political momentum for legalizing weed , but significant hurdles remain ( Texas Tribune )
Measles is spreading in Washington state as US loses its elimination status ( KUOW )
Health news we’ve flagged from other outlets:
An unspoken rule spreads through biotech: share nothing ( New York Times )
Scientists heralded a blue wave. But will they miss Susan Collins? ( Stat )
How Kennedy let measles run wild in America ( Reuters )
Opinions related to health submitted to The Hill:
Check out The Hill’s Healthcare page for the latest coverage.
400 N Capitol Street NW Suite 650, Washington, DC 20001
If you believe this has been sent to you in error, please safely unsubscribe .
Topics in this story
Gathered from external sources. Rights to this text belong to whoever originally published it.